期刊文献+

蛋白质组学在阿尔采末病中的研究进展

The Progress in Proteomics Researches of Alzheimer' s Disease
下载PDF
导出
摘要 蛋白质组学是基因组时代产生的一门重要学科,是从整体水平对蛋白质的综合分析。阿尔采末病(A lzheimer's d isease,AD)是常见而复杂的神经退行性疾病之一。应用蛋白质组学对AD进行研究,不仅可在蛋白质水平上揭示疾病的本质,还有助于全面探讨AD的病理机制,建立诊断标准,发现药物治疗靶点。本文从病理机制(特别是蛋白质翻译后修饰)、发现临床生物标签及治疗药物三个方面,对蛋白质组学在AD中的研究进展进行了综述。 Proteomics , an important discipline in genomic era , is the integrated study of protein properties on a large scale. Application of proteomics researches in Alzheimer's ,disease ( AD), which is one of most common and complex neurodegeneration disorders, we can not only elucidate the essential issues of disease in protein level, but give a whole view in the pathological mechanisms identification, diagnosis and therapeutic targets discovery as well. The three aspects about the progresses in proteomics researches of AD were reviewed in this article.
作者 刘斌 王晓良
出处 《生理科学进展》 CAS CSCD 北大核心 2006年第1期11-16,共6页 Progress in Physiological Sciences
基金 国家高技术研究发展计划(973)项目资助课题(2004CB518906)
关键词 蛋白质组学 阿尔采末病 翻译后修饰 生物标签 药物研发 proteomics Alzheimer's disease post-translational modification biomarker drug discovery
  • 相关文献

参考文献20

  • 1Boyd-Kimball D, Castegna A, Sultana R, et al. Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: Implications for Alzheimer's disease. Brain Res,2005, 1044 : 206 - 215.
  • 2Castegna A, Aksenov M, Aksenova M, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part Ⅰ: creatine kinase BB, glutamine synthase, and ubiquitin carboxy- terminal hydrolase L-1. Free Radic Biol Med, 2002, 33 : 562 -571.
  • 3Castegna A, Aksenov M, Thongboonkerd V, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part Ⅱ: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem, 2002, 82 : 1524 - 1532.
  • 4Choi J, Forster MJ, McDonald SR, et al. Proteomic identification of specific oxidized proteins in ApoE-knockout mice:relevance to Alzheimer's disease. Free Radic Biol Med,2004, 36 : 1155 - 1162.
  • 5Castegna A, Thongboonkerd V, Klein JB, et al. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neuroehem, 2003, 85 : 1394 - 1401.
  • 6Sergeant N, Bombois S, Ghestem A, et al. Truncated beta-amyloid pepticle species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem,2003, 85 : 1581 - 1591.
  • 7Sobow T, Flirski M, Liberski PP. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease. Acta Neurobiol Exp, 2004, 64 : 53 - 70.
  • 8Zhang R, Barker L, Pinchev D, et al. Mining biomarkers in human sera using proteomic tools. Proteomics, 2004,4 : 244 - 256.
  • 9Steel LF, Trotter MG, Nakajima PB, et al. Efficient and specific removal of albumin from human serum samples.Mol Cell Proteomics, 2003, 2 : 262 - 270.
  • 10Yu HL, Chertkow HM, Bergman H, et al. Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics, 2003, 3 : 2240 - 2248,.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部